BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28515418)

  • 1. Automatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease.
    Sharma K; Rupprecht C; Caroli A; Aparicio MC; Remuzzi A; Baust M; Navab N
    Sci Rep; 2017 May; 7(1):2049. PubMed ID: 28515418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
    van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
    J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
    J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
    Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
    Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
    Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
    Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Ge Y; Tao C; Zhu J; Chapman AB; Torres VE; Yu AS; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):576-84. PubMed ID: 26797708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
    Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
    J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully Automated Segmentation of Polycystic Kidneys From Noncontrast Computed Tomography: A Feasibility Study and Preliminary Results.
    Turco D; Valinoti M; Martin EM; Tagliaferri C; Scolari F; Corsi C
    Acad Radiol; 2018 Jul; 25(7):850-855. PubMed ID: 29331360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep learning-based automated kidney and cyst segmentation of autosomal dominant polycystic kidney disease using single vs. multi-institutional data.
    Schmidt EK; Krishnan C; Onuoha E; Gregory AV; Kline TL; Mrug M; Cardenas C; Kim H;
    Clin Imaging; 2024 Feb; 106():110068. PubMed ID: 38101228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.
    Bae K; Park B; Sun H; Wang J; Tao C; Chapman AB; Torres VE; Grantham JJ; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1089-97. PubMed ID: 23520042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nnUNet for Automatic Kidney and Cyst Segmentation in Autosomal Dominant Polycystic Kidney Disease.
    Krishnan C; Schmidt E; Onuoha E; Mrug M; Cardenas CE; Kim H
    Curr Med Imaging; 2024; 20():1-9. PubMed ID: 38389364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Learning Automation of Kidney, Liver, and Spleen Segmentation for Organ Volume Measurements in Autosomal Dominant Polycystic Kidney Disease.
    Sharbatdaran A; Romano D; Teichman K; Dev H; Raza SI; Goel A; Moghadam MC; Blumenfeld JD; Chevalier JM; Shimonov D; Shih G; Wang Y; Prince MR
    Tomography; 2022 Jul; 8(4):1804-1819. PubMed ID: 35894017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.
    Turco D; Busutti M; Mignani R; Magistroni R; Corsi C
    Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
    Woznicki P; Siedek F; van Gastel MDA; Dos Santos DP; Arjune S; Karner LA; Meyer F; Caldeira LL; Persigehl T; Gansevoort RT; Grundmann F; Baessler B; Müller RU
    Kidney360; 2022 Dec; 3(12):2048-2058. PubMed ID: 36591351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease.
    Kline TL; Edwards ME; Fetzer J; Gregory AV; Anaam D; Metzger AJ; Erickson BJ
    Abdom Radiol (NY); 2021 Mar; 46(3):1053-1061. PubMed ID: 32940759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.
    King BF; Reed JE; Bergstralh EJ; Sheedy PF; Torres VE
    J Am Soc Nephrol; 2000 Aug; 11(8):1505-1511. PubMed ID: 10906164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
    Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
    Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
    Chebib FT; Torres VE
    Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.
    Turco D; Severi S; Mignani R; Aiello V; Magistroni R; Corsi C
    Acad Radiol; 2015 Nov; 22(11):1376-84. PubMed ID: 26276168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.